Walden Group Arranges the sale of Argentum Medical, LLC to Shore Capital Partners


The Walden Group is pleased to announce that it represented Argentum Medical, LLC, an advanced woundcare company, in its sale of equity to Shore Capital Partners.

Argentum's core platform technology, Silverlon, is a uniquely designed silver-plated nylon matrix that releases potent silver ions into the wound without staining the skin or increasing bioburden. Validated by several clinical studies, Silverlon dressings are used by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure wound therapy.

In 2015, the U.S. Biomedical Advanced Research and Development Authority (“BARDA”) awarded Argentum a multi-year contract up to $16.5 million to support new Silverlon indications for ionizing radiation and sulfar mustard burns. In addition, BARDA selected Silverlon from a broad range of wound care products for inclusion on an annual basis in the Strategic National Stockpile.

The Walden Group prepared Argentum and its principals from the inception of the transaction and helped to negotiate the terms and steer the transaction to closing.

Shore Capital's press release announcing the transaction can be viewed here: Shore - Argentum Press Release.

On the legal side, Griffen WIlliams LLP (Pat Griffen) and Moomjian, Waite & Coleman, LLP (Gary Moomjian) represented Argentum, and Winston & Strawn LLP (Matt Bergman and Jamie Lepri) represented Shore Capital.

About The Walden Group

The Walden Group is a healthcare investment banking and consulting firm combining merger & acquisition and strategic consulting services. Its approach is close-to-operations in lockstep with business development and C-Suite executives of medical device, diagnostic, healthcare IT, service and other companies within the sector. It represents companies seeking to divest operations and find a "home" within a larger company or private equity firm that can better commercialize its product lines. It also represents larger operating companies and financial sponsors seeking to grow by corporate acquisition. It is expert in identifying and building rapport with strategically fitted candidates and guiding transactions to completion. See www.waldenmed.com

The Walden Group, Inc.
560 White Plains Rd.
Tarrytown, NY 10591


keywords: healthcarem&a, healthcareinvestmentbanking